Barry Investment Advisors, LLC Pfizer Inc Transaction History

Barry Investment Advisors, LLC

$322 Million
Q3 2024

A detailed history of Barry Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Barry Investment Advisors, LLC holds 198,149 shares of PFE stock, worth $5.08 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares

198,149

Previous 197,835 0.16%

Holding current value

$5.08 Million

Previous $5.54 Million 3.6%

% of portfolio

1.78%

Previous 1.89%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $8,697 - $9,856	314 Added 0.16%	198,149 $5.73 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $132,918 - $155,755	5,262 Added 2.73%	197,835 $5.54 Million
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $54,964 - $63,116	2,123 Added 1.11%	192,573 $5.34 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $16,801 - $21,823	-643 Reduced 0.34%	190,450 $5.48 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $14,697 - $17,179	458 Added 0.24%	191,093 $6.34 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $102,075 - $118,098	-2,826 Reduced 1.46%	190,635 $6.99 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $89,927 - $117,072	2,283 Added 1.19%	193,461 $7.89 Million
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $82,915 - $108,237	-1,986 Reduced 1.03%	191,178 $0
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $256,783 - $313,468	-5,868 Reduced 2.95%	193,164 $8.45 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $596,561 - $707,334	-12,821 Reduced 6.05%	199,032 $10.4 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $388,600 - $481,524	-8,494 Reduced 3.85%	211,853 $11 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $114,828 - $170,213	-2,779 Reduced 1.25%	220,347 $13 Million
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $77,401 - $99,428	-1,972 Reduced 0.88%	223,126 $9.6 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $158,363 - $179,398	-4,410 Reduced 1.92%	225,098 $8.82 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $254,457 - $286,976	7,598 Added 3.42%	229,508 $8.32 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $41,603 - $52,902	1,243 Added 0.56%	221,910 $8.17 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $60,801 - $71,333	1,915 Added 0.88%	220,667 $8.1 Million
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $113,070 - $137,171	3,754 Added 1.75%	218,752 $7.15 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $68,250 - $97,515	2,525 Added 1.19%	214,998 $7.02 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $105,771 - $120,037	3,213 Added 1.54%	212,473 $8.37 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $66,117 - $85,734	-2,035 Reduced 0.96%	209,260 $7.52 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $95,038 - $106,706	-2,570 Reduced 1.2%	211,295 $9.15 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $221,325 - $243,162	-5,902 Reduced 2.69%	213,865 $9.08 Million
Q4 2018 Jan 28, 2019	BUY	$38.47 - $43.86 $41,970 - $47,851	1,091 Added 0.5%	219,767 $9.59 Million
Q3 2018 Oct 19, 2018	SELL	$34.47 - $41.81 $2.41 Million - $2.92 Million	-69,946 Reduced 24.23%	218,676 $9.64 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $34,332 - $36,601	-1,041 Reduced 0.36%	288,622 $10.5 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $256,205 - $297,233	-8,029 Reduced 2.7%	289,663 $10.3 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $65,888 - $69,909	-1,981 Reduced 0.66%	297,692 $10.8 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $9.29 Million - $10.2 Million	299,673	299,673 $10.7 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barry Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barry Investment Advisors, LLC with notifications on news.

Account

Barry Investment Advisors, LLC Pfizer Inc Transaction History